Bibliographic Details
Title: |
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial |
Authors: |
Shaw, Alice T, Gandhi, Leena, Gadgeel, Shirish, Riely, Gregory J, Cetnar, Jeremy, West, Howard, Camidge, D Ross, Socinski, Mark A, Chiappori, Alberto, Mekhail, Tarek, Chao, Bo H, Borghaei, Hossein, Gold, Kathryn A, Zeaiter, Ali, Bordogna, Walter, Balas, Bogdana, Puig, Oscar, Henschel, Volkmar, Ou, Sai-Hong Ignatius |
Source: |
In The Lancet Oncology February 2016 17(2):234-242 |
Database: |
ScienceDirect |